These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 32868192)

  • 1. The fragility of humoral immunity as a physiological safety marker for healthcare workers to return after COVID-19 convalescence.
    Silva VL; Dias VC; Watanabe ASA; Ferreira Machado AB; Furtado AO; Diniz CG
    J Microbiol Immunol Infect; 2021 Feb; 54(1):141-143. PubMed ID: 32868192
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive and Parallel Decline of Humoral and T-Cell Immunity in Convalescent Healthcare Workers with Asymptomatic or Mild-to-Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Casado JL; Vizcarra P; Velasco H; Hammerle J; McGee A; Fernandez-Escribano M; Vallejo A
    J Infect Dis; 2021 Jul; 224(2):241-245. PubMed ID: 33961690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: Comment.
    Daungsupawong H; Wiwanitkit V
    J Immunol Methods; 2024 Jun; 529():113671. PubMed ID: 38593868
    [No Abstract]   [Full Text] [Related]  

  • 4. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.
    Tan AT; Linster M; Tan CW; Le Bert N; Chia WN; Kunasegaran K; Zhuang Y; Tham CYL; Chia A; Smith GJD; Young B; Kalimuddin S; Low JGH; Lye D; Wang LF; Bertoletti A
    Cell Rep; 2021 Feb; 34(6):108728. PubMed ID: 33516277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
    Ni L; Ye F; Cheng ML; Feng Y; Deng YQ; Zhao H; Wei P; Ge J; Gou M; Li X; Sun L; Cao T; Wang P; Zhou C; Zhang R; Liang P; Guo H; Wang X; Qin CF; Chen F; Dong C
    Immunity; 2020 Jun; 52(6):971-977.e3. PubMed ID: 32413330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B careful: Humoral responses and COVID-19 severity.
    Fanous H; Guerrero-Pena A; Pillai A
    Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33277373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The known unknowns of T cell immunity to COVID-19.
    Karlsson AC; Humbert M; Buggert M
    Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33208380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.
    Yamamoto S; Saito M; Nagai E; Toriuchi K; Nagai H; Yotsuyanagi H; Nakagama Y; Kido Y; Adachi E
    J Med Virol; 2021 Feb; 93(2):692-694. PubMed ID: 32897566
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2.
    Mveang Nzoghe A; Essone PN; Leboueny M; Maloupazoa Siawaya AC; Bongho EC; Mvoundza Ndjindji O; Avome Houechenou RM; Agnandji ST; Djoba Siawaya JF
    Immun Inflamm Dis; 2021 Mar; 9(1):128-133. PubMed ID: 33320447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Humoral Immune Response in Persons with Asymptomatic or Mild SARS-CoV-2 Infection, Vietnam.
    Mai HK; Trieu NB; Long TH; Thanh HT; Luong ND; Huy LX; Nguyet LA; Man DNH; Anderson DE; Thanh TT; Chau NVV; Thwaites G; Wang LF; Van Tan L; Hung DT
    Emerg Infect Dis; 2021 Feb; 27(2):663-666. PubMed ID: 33496647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
    Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
    J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and humoral immune response in healthcare workers with COVID-19 in a teaching hospital in Belgium.
    Vandercam G; Simon A; Scohy A; Belkhir L; Kabamba B; Rodriguez-Villalobos H; Yombi JC
    J Hosp Infect; 2020 Dec; 106(4):713-720. PubMed ID: 32956787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: "Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2" by Krsak
    Mishra BK; Bhattacharya D; Kshatri JS; Pati S
    Viral Immunol; 2021 Nov; 34(9):658. PubMed ID: 34672807
    [No Abstract]   [Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study.
    Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW
    Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery.
    Liu A; Wang W; Zhao X; Zhou X; Yang D; Lu M; Lv Y
    Clin Microbiol Infect; 2020 Dec; 26(12):1703-1705. PubMed ID: 32653658
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
    Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
    Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated and humoral adaptive immune responses to SARS-CoV-2 are lower in asymptomatic than symptomatic COVID-19 patients.
    Mazzoni A; Maggi L; Capone M; Spinicci M; Salvati L; Colao MG; Vanni A; Kiros ST; Mencarini J; Zammarchi L; Mantengoli E; Menicacci L; Caldini E; Romagnani S; Liotta F; Morettini A; Rossolini GM; Bartoloni A; Cosmi L; Annunziato F
    Eur J Immunol; 2020 Dec; 50(12):2013-2024. PubMed ID: 33080068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild Cytokine Elevation, Moderate CD4
    Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
    Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave.
    Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I
    PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.
    Sasisekharan V; Pentakota N; Jayaraman A; Tharakaraman K; Wogan GN; Narayanasami U
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33446512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.